Summary
By using an antiserum raised against dopamine bound to bovine serum albumin, thinner dopamine-labeled nerve terminals were visualized immunohistochemically within neocortical areas, in addition to well-documented dopaminergic innervation into the prefrontal and limbic cortices.
References
Berger, B., Thierry, A. M., Tassin, J. P., and Moyne, M. A., Brain Res.106 (1976) 133.
Berger, B., Verney, C., Alvarez, C., Vigny, A., and Helle, K. B., Neuroscience14 (1985) 983.
Björklund, A., and Lindvall, O., in: Handbook of Chemical Neuroanatomy, vol. 2, p. 55. Eds A. Björklund, T. Hökfelt and M. J. Kuhar. Elsevier, Amsterdam 1984.
Geffard, M., Buijs, R., Seguela, P., Pool, C. W., and Le Moal, M., Brain Res.294 (1984) 161.
Geffard, M., Henrich-Rock, A.-M., Dulluc, J., and Seguela, P., Neurochem. int.7 (1985) 403.
Krieg, W. J. S., J. comp. Neurol.84 (1946) 221.
Lindvall, O., and Björklund, A., in: Chemical Neuroanatomy, p. 229. Ed. P. C. Emson. Raven Press, New York 1983.
Lindvall, O., Björklund, A., and Divac, I., Brain Res.142 (1978) 1.
Sakai, M., Yoshida, M., Karasawa, N., Teramura, M., Ueda, H., and Nagatsu, I., Experientia43 (1987) 298.
Sternberger, L., in: Immunocytochemistry, p. 90. Wiley, New York 1986.
Van Eden, C. G., Hoorneman, E. M. D., Buijs, R. M., Matthijssen, M. A. H., Geffard, M., and Uylings, H. B. M., Neuroscience22 (1987) 849.
Yoshida, M., Karasawa, N., Ito, M., Sakai, M., and Nagatsu, I., Neurosci. Res.3 (1986) 356.
Yoshida, M., Teramura, M., Karasawa, N., Sakai, M., and Nagatsu, I., Biogenic Amines4 (1987) 135.
Yoshida, M., Teramura, M., Sakai, M., Karasawa, N., Nagatsu, T., and Nagatsu, I., Brain Res.410 (1987) 169.
Author information
Authors and Affiliations
Additional information
This study was supported in part by a Grant-in-Aid for Scientific Research on Priority Areas, Japanese Ministry of Education, Science, Culture (No. 62623002).
Rights and permissions
About this article
Cite this article
Yoshida, M., Sakai, M., Kani, K. et al. The dopaminergic innervation as observed by immunohistochemistry using anti-dopamine serum in the rat cerebral cortex. Experientia 44, 700–702 (1988). https://doi.org/10.1007/BF01941033
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01941033